The challenge in "Women's Neuromodulation"

NeuroGyn AG introduces PosStim™, a next-generation implantable neurostimulator engineered for Genital Nerve Stimulation (GNS) — a novel, minimally invasive therapy targeting pelvic nerve disorders that affect bladder and bowel control, sexual function, and mobility.
Developed in collaboration with imec, PosStim™ combines Swiss medical innovation with European micro-engineering excellence to establish a new benchmark in precision pelvic neuromodulation.

The PosStim™ system embodies simplicity, safety, and performance. Its compact design allows discreet implantation behind the pubic bone, fully invisible under the skin. The device is pre-connected, pre-programmed, and functionally verifiable before surgery, ensuring maximal reliability and minimal procedural time. Once implanted, patients can wirelessly manage their therapy through a single handheld controller and mobile app, enabling complete autonomy without the need for repeated clinical adjustments.

Unlike traditional sacral or pudendal neuromodulation systems that require complex implantation and programming, PosStim™ is designed for routine gynecological practice — reproducible, cost-efficient, and highly scalable. Its long-life dual-battery system, inductive wireless charging, and optimized low-power architecture guarantee sustained therapeutic delivery for more than fifteen years under normal life conditions.

PosStim™ reflects more than two decades of clinical experience in neuropelveology and introduces a new standard in patient-centered neurotechnology — merging advanced engineering, intuitive usability, and minimally invasive access. By addressing the functional core of pelvic disorders through targeted genital nerve stimulation, the PosStim™ platform opens the door to a new era in personalized pelvic health.